EIKONOKLASTES THERAPEUTICS, INC. Form D/A amendment
Biotech · Series B · Regulation D 506(b) · OH · Filed October 6, 2026
View all SEC Form D filings for EIKONOKLASTES THERAPEUTICS, INC.- Offering amount
- $18.6M
- Exemption
- Reg D 506(b)
- Filing type
- Form D/A
- Form D industry group
- Pharmaceuticals
- Issuer state
- OH
- Filing date
- October 6, 2026
- Signature date
- October 5, 2026
- CIK
- 0001805698
What is a Form D filing?
A Form D is the notice a private company files with the U.S. Securities and Exchange Commission when raising capital through an offering exempt under Regulation D (Rule 506(b), 506(c), or 504). It discloses the offering but is not a solicitation, an endorsement, or a statement of investment merit. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Public filing directories
Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Filing snapshot
EIKONOKLASTES THERAPEUTICS, INC. (based in OH) filed an SEC Form D/A amendment on October 6, 2026, disclosing a $18.6M offering of securities under Rule 506(b) of Regulation D. The issuer selected Pharmaceuticals as its Form D industry group. FormDFlow has tagged the issuer's sector as Biotech. This page reflects the public filing as recorded in SEC EDGAR; see the source document for the complete disclosure.
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
Source
FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.